|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
20.550 -0.750 (-3.521%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 2.420% | 2.435% | 2.400% | 2.474% | 2.473% |
| ROAE (%) | 12.694% | 13.121% | 13.123% | 13.851% | 13.857% |
| Return on Capital Employed (%) | 6.380% | 6.568% | 6.682% | 6.701% | 6.836% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 8.132% | 8.591% | 8.454% | 8.835% | 8.825% |
| EBITDA Margin (%) | 4.235% | 4.501% | 4.464% | 4.634% | 4.497% |
| Pre-tax Profit Margin (%) | 3.271% | 3.362% | 3.263% | 3.418% | 3.236% |
| Net Profit Margin (%) | 1.518% | 1.544% | 1.489% | 1.575% | 1.470% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.395 X | 1.359 X | 1.327 X | 1.312 X | 1.289 X |
| Quick Ratio (X) | 1.146 X | 1.100 X | 1.092 X | 1.081 X | 1.050 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 68.618% | 69.825% | 70.289% | 71.100% | 71.492% |
| Total Debt / Total Assets (%) | 19.244% | 19.078% | 20.383% | 22.018% | 20.430% |
| Net Debt / Total Assets (%) | 2.601% | 3.939% | 7.405% | 5.895% | 5.909% |
| Total Debt / Shareholders' Funds (%) | 98.927% | 102.235% | 110.474% | 121.590% | 116.273% |
| Long Term Debt / Shareholders' Funds (%) | 23.135% | 21.973% | 18.855% | 21.579% | 24.188% |
| Net Debt / Shareholders' Funds (%) | 13.372% | 21.109% | 40.136% | 32.557% | 33.628% |
| Net Cash / (Debt) ($) | (9.973B) | (14.369B) | (24.839B) | (18.349B) | (15.947B) |
| Net Cash / (Debt) per share ($) | (3.196) | (4.604) | (7.959) | (5.880) | (5.366) |
| Total Debt / Capital Employed (%) | 51.994% | 53.608% | 58.884% | 63.889% | 60.285% |
| Interest Coverage Ratio (X) | 7.600 X | 6.273 X | 5.526 X | 5.555 X | 4.997 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 40.277 Day | 40.652 Day | 37.719 Day | 39.334 Day | 36.705 Day |
| Receivables Turnover (Day) | 108.353 Day | 112.759 Day | 110.936 Day | 107.007 Day | 98.145 Day |
| Payables Turnover (Day) | 86.794 Day | 87.760 Day | 84.433 Day | 85.156 Day | 78.968 Day |
| Remarks: | Real time quote last updated: 21/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,703,875 |
| %Change | -9.759% |
| EPS / (LPS) | RMB 1.190 |
| NBV Per Share (¥) | RMB 24.207 |